Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

Dermatology Case Question: May

Alisa Femia, MD, and Joseph F. Merola, MD  |  May 1, 2013

Test your diagnostic knowledge with this cutaneous eruption on the palms and soles

Filed under:Conditions

ACR 2014 Winter Rheumatology Symposium Keeps Tradition Alive

Susan Bernstein  |  May 1, 2013

Clinicians gather each year in Snowmass, Colo. to learn from top experts in rheumatic disease—and ski with them

Filed under:Education & Training Tagged with:ACR 2014 Winter Rheumatology Symposiumeducation and training

Speak Out Rheum: How the U.K. and U.S. Healthcare Models Stack Up

Chris Deighton, MD  |  May 1, 2013

A national, socialized medical system has significant advantages over the often-fragmented, unequally distributed U.S. system of healthcare, says one rheumatologist

Filed under:Legislation & Advocacy Tagged with:Healthcareregulation and legislation

ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy

Kimberly Retzlaff  |  May 1, 2013

Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging

Filed under:ConditionsMeeting Reports Tagged with:ACR Winter Rheumatology SymposiumBiologicsInfectionMethotrexateRheumatic Diseasevaccination

ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise

Staff  |  May 1, 2013

Toxicity and appropriate targeting are challenges for small molecule researchers

Filed under:Drug UpdatesMeeting ReportsResearch Rheum Tagged with:AC&RACR Winter Rheumatology Symposiumkinase inhibitorResearch

Fellow’s Forum Case Report: Diagnosing Antisynthetase Syndrome

Fawad Aslam, MBBS, and Elizabeth B. Russell, MD  |  May 1, 2013

A variable combination of interstitial lung disease, myopathy, fever, joint involvement, and mechanic’s hands characterize this systemic autoimmune syndrome

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antisynthetase SyndromeInterstitial Lung Diseasepatient care

Ethics Forum: Patients’ Unplanned Pregnancies Present Counseling Issues for Rheumatologists

Bonnie L. Bermas, MD  |  May 1, 2013

What to consider when advising a pregnant patient with rheumatoid arthritis whose fetus has been exposed to teratogenic medications

Filed under:Professional Topics Tagged with:Methotrexatepatient safetypregnancy

Prednisone Might be the Missing Ingredient in the American College of Rheumatology’s Recommendations for Treating Patients with Rheumatoid Arthritis

John Kirwan, MD  |  April 1, 2013

A combination therapy with glucocorticoids may be the gold standard for treating patients with rheumatoid arthritis (RA)

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:AC&RGlucocorticoidsprednisoneRARheumatoid arthritisSteroid

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD  |  April 1, 2013

 Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:GlucocorticoidsprednisoneRARheumatoid arthritis

Why Oral Corticosteroids Should Not be Used in Patients with Rheumatoid Arthritis

Anthony S. Russell, MA, MB, BCHIR  |  April 1, 2013

 Steroid use in patients with rheumatoid arthritis (RA) has been linked to higher mortality rates, greater rate of infections, more cases of pneumonia, and serious gastrointestinal events

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:Oral CorticosteroidsRARheumatoid arthritisSteroid

  • « Previous Page
  • 1
  • …
  • 86
  • 87
  • 88
  • 89
  • 90
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences